|
 |
|
|||||||
|
|||||||||
© 2002 by the American Diabetes Association, Inc.
Pulsatile Insulin Release From Islets Isolated From Three Subjects With Type 2 Diabetes
1 Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
2 Endocrinology and Diabetes Unit, IDIBAPS, Hospital Clinic, School of Medicine, Barcelona University, Barcelona, Spain
Plasma insulin in healthy subjects shows regular oscillations, which are important for the hypoglycemic action of the hormone. In individuals with type 2 diabetes, these regular variations are altered, which has been implicated in the development of insulin resistance and hyperglycemia. The origin of the change is unknown, but derangement of the islet secretory pattern has been suggested as a contributing cause. In the present study, we show the dynamics of insulin release from individually perifused islets isolated from three subjects with type 2 diabetes. Insulin release at 3 mmol/l glucose was 10.5 ± 4.5 pmol · g-1 · s-1 and pulsatile (0.26 ± 0.05 min-1). In islets from one subject, 11 mmol/l glucose transiently increased insulin release by augmentation of the insulin pulses without affecting the frequency. Addition of 1 mmol/l tolbutamide did not increase insulin release. In islets from the remaining subjects, insulin release was not affected by 11 mmol/l glucose. Tolbutamide transiently increased insulin release in islets from one subject. Insulin release from four normal subjects at 3 mmol/l glucose was 4.3 ± 0.8 pmol · g-1 · s-1 and pulsatile (0.23 ± 0.03 min-1). At 11 mmol/l glucose, insulin release increased in islets from all subjects. Tolbutamide further increased insulin release in islets from two subjects. It is concluded that islets from the three individuals with type 2 diabetes release insulin in pulses. The impaired secretory response to glucose may be related to impaired metabolism before mitochondrial degradation of the sugar.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  R. A. Ritzel, J. J. Meier, C.-Y. Lin, J. D. Veldhuis, and P. C. Butler Human Islet Amyloid Polypeptide Oligomers Disrupt Cell Coupling, Induce Apoptosis, and Impair Insulin Secretion in Isolated Human Islets Diabetes, January 1, 2007; 56(1): 65 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Ritzel, J. D. Veldhuis, and P. C. Butler The mass, but not the frequency, of insulin secretory bursts in isolated human islets is entrained by oscillatory glucose exposure Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E750 - E756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Del Guerra, R. Lupi, L. Marselli, M. Masini, M. Bugliani, S. Sbrana, S. Torri, M. Pollera, U. Boggi, F. Mosca, et al. Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes Diabetes, March 1, 2005; 54(3): 727 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Marchetti, S. Del Guerra, L. Marselli, R. Lupi, M. Masini, M. Pollera, M. Bugliani, U. Boggi, F. Vistoli, F. Mosca, et al. Pancreatic Islets from Type 2 Diabetic Patients Have Functional Defects and Increased Apoptosis That Are Ameliorated by Metformin J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5535 - 5541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Deng, M. Vatamaniuk, X. Huang, N. Doliba, M.-M. Lian, A. Frank, E. Velidedeoglu, N. M. Desai, B. Koeberlein, B. Wolf, et al. Structural and Functional Abnormalities in the Islets Isolated From Type 2 Diabetic Subjects Diabetes, March 1, 2004; 53(3): 624 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Ritzel, J. D. Veldhuis, and P. C. Butler Glucose Stimulates Pulsatile Insulin Secretion from Human Pancreatic Islets by Increasing Secretory Burst Mass: Dose-Response Relationships J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 742 - 747. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |